Gavi / Serum Institute of India

Ensured LMIC access to COVID-19 vaccines

Gavi and the Serum Institute of India are accelerating the manufacture and delivery of up to 200 million doses of COVID-19 vaccines for low- and middle-income countries.
  • Domain
  • Investment type
  • Status
  • Initial investment
  • Partnered in
  • Investment lead
    Natalie Revelle
  • Headquarters
  • Program strategy
    COVID-19 Response

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.